Hemocoagulometer

Hemocoagulometers are devices that are used to measure blood parameters associated with coagulation (clotting). These devices help doctors and healthcare professionals assess the health of patients and diagnose various diseases associated with bleeding disorders.

Hemocoagulometric parameters include blood clotting time, activity of coagulation factors, fibrinogen content and other proteins involved in the coagulation process. These parameters can be measured in vitro or in vivo.

In medicine, hemocoagulometers are widely used to diagnose various diseases. For example, in cases of deep vein thrombosis or pulmonary embolism, hemocoagulometric analysis can help identify the presence of blood clots or determine their size.

In addition, hemocoagulometers are used in cardiology, surgery and other medical fields. They help assess the risk of bleeding or blood clots after surgery or injury, and also help monitor anticoagulant treatment.

One of the main advantages of hemocoagulometers is that they allow you to quickly and accurately measure blood parameters related to coagulation. This allows doctors and healthcare workers to quickly assess the patient’s condition and take the necessary measures to treat it.

However, like any other medical device, hemocoagulometers have their limitations and disadvantages. For example, the accuracy of a measurement depends on the quality of the reagents and equipment, as well as the qualifications of the personnel performing the analysis. In addition, some patients may have individual bleeding characteristics, which may affect test results.

Thus, hemocoagulometry is an important tool in medicine, which allows you to quickly and accurately assess the state of the blood coagulation system and diagnose various diseases. However, like other medical devices, hemocoagulometers require qualified personnel and quality equipment to obtain accurate results.

Hemostasis is the process of maintaining the fluid state of blood in the body. It includes the process of hematopoiesis, i.e. production of blood by various types of cells. Hemotest is a set of methods for studying blood and diagnosing diseases of the hematopoietic system. One of the methods of hematology is the study of the blood coagulation system.

**Diseases of hemostasis**. Severe bleeding or, on the contrary, delayed bleeding, dysregulation of coagulation or anticoagulation processes may indicate dysfunction of the main components of hemostasis: * platelets, * coagulation factors * fibrinolysis.

Pathology of the hemostatic sphere can be hereditary, secondary in nature, or result from infection. The body can respond to physical and chemical damaging factors by having an altered general rheological (blood fluidity) and procoagulant profile. We are talking primarily about a systemic response to changes in hemodynamics, determining the level of fibrinolytic activity in the serum and taking a hemostasiogram with hemodilution - they allow us to differentiate reactions of increased coagulation or vascular permeability (for example, hemorrhagic vasculitis), as well as between intravascular aggregation processes or a violation of the plasticity of capillaries, indicating systemic microangiopathy. Determination of individual indicators of the hemostasiological profile provides guidance in choosing the direction of conservative therapy, necessary in the absence of basic specific treatment, to monitor the patient’s condition. Also, the main points of the hemostasiogram are taken into account when developing the plan and scope of surgical interventions.

The main tests of the hemostasiogram: bleeding time with counting the number of blood rebounds when performing a test with active tension of the leg capsule, the concentration of fibrinogen in the blood plasma, the study of platelet aggregation. In children, blood clotting time is more often determined: the duration of a complete laboratory three-color hemostasis system.

Normal blood test values ​​vary depending on the laboratory, but the most common values ​​include: * APTT - activated partial thromboplastin time - 25 - 36 s. * Prothrombin time (PTI-INR) - average 80%, but may not be